These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Analysis of 4-methyl-piperazine-1-carbodithioic acid 3-cyano-3,3-diphenyl-propyl ester hydrochloride and its major metabolites in rat plasma and tissues by LC-MS/MS. Jiang X; Ling X; Han F; Li R; Cui J J Sep Sci; 2007 Aug; 30(13):2080-5. PubMed ID: 17638372 [TBL] [Abstract][Full Text] [Related]
3. [Tolerability and pharmacological properties of the piperazine salt of phenasal]. Lebedeva MN; Gladkikh VF; Sazonova EV Med Parazitol (Mosk); 1971; 40(6):653-7. PubMed ID: 5147618 [No Abstract] [Full Text] [Related]
4. Psycho-sedative properties of some (indolylethyl) piperazine derivatives. Abdul Hameed JM; Haley TJ Proc West Pharmacol Soc; 1965; 8():7-10. PubMed ID: 5861452 [No Abstract] [Full Text] [Related]
5. Synthesis and pharmacological screening of a group of piperazine derivatives. Analgesic activity. Nikolova M; Fajad K; Natova L Farmaco; 1993 Apr; 48(4):459-72. PubMed ID: 8357464 [TBL] [Abstract][Full Text] [Related]
6. [Synthesis and central none-opioid analgesic activity of SIPI5047]. Li JQ; Huang LY; Chen XJ; Weng ZJ; Zhang CN Yao Xue Xue Bao; 2008 Jun; 43(6):611-8. PubMed ID: 18822964 [TBL] [Abstract][Full Text] [Related]
7. [Inhibition of catabolism of liver phospholipids by 2-(4' methyl piperazino 1' methyl)1-3 diaza fluoranthene oxide 1 (AC-3579)]. Thys O; Graff GL; Hildebrand J; Gerin Y C R Seances Soc Biol Fil; 1973; 167(10):1487-90. PubMed ID: 4793571 [No Abstract] [Full Text] [Related]
8. [Contribution to the pharmacology of piperazine]. Lorenz D; Steinmann HW Arztl Forsch; 1966 Dec; 20(12):636-8. PubMed ID: 6014388 [No Abstract] [Full Text] [Related]
10. Possible mechanism of action of piperazine derivatives on liver mitochondria. I--Effect of p-toluyl m-nitro-piperazine (p-TNP). Souza JF; Campello AP; Klüppel ML Res Commun Chem Pathol Pharmacol; 1981 Oct; 34(1):115-26. PubMed ID: 6273980 [TBL] [Abstract][Full Text] [Related]
11. [Central pharmacological activity of new piperazine derivatives]. Zebrowska-Lupina I; Kolasa K; Rajtar G; Ossowska G; Stelmasiak M; Chodkowska A; Porowska A; Kleinrok Z Acta Pol Pharm; 1984; 41(6):679-85. PubMed ID: 6543571 [No Abstract] [Full Text] [Related]
12. [Design and synthesis of aralkyl-ketone piperazine derivatives and their antalgic activities]. Li JQ; Huang LY; Chen JX; Weng ZJ; Zhang CN Yao Xue Xue Bao; 2007 Nov; 42(11):1166-75. PubMed ID: 18300474 [TBL] [Abstract][Full Text] [Related]
13. Experimental teratogenicity of structurally similar compounds with or without piperazine-ring: a preliminary report. Druga A; Nyitray M; Szaszovszky E Pol J Pharmacol Pharm; 1980; 32(2):199-204. PubMed ID: 6109278 [TBL] [Abstract][Full Text] [Related]
14. Preliminary evaluation of anticonvulsant activity and neurotoxicity of some 1,4-substituted piperazine derivatives. Marona H; Gunia A; Słoczyńska K; Rapacz A; Filipek B; Cegła M; Opoka W Acta Pol Pharm; 2009; 66(5):571-8. PubMed ID: 19894654 [TBL] [Abstract][Full Text] [Related]
15. Orally active inhibitors of human leukocyte elastase. III. Identification and characterization of metabolites of L-694,458 by liquid chromatography-tandem mass spectrometry. Luffer-Atlas D; Vincent SH; Painter SK; Arison BH; Stearns RA; Chiu SH Drug Metab Dispos; 1997 Aug; 25(8):940-52. PubMed ID: 9280402 [TBL] [Abstract][Full Text] [Related]
16. Central serotoninmimetic action of phenylpiperazines. Maj J; Lewandowska A Pol J Pharmacol Pharm; 1980; 32(4):495-504. PubMed ID: 7255267 [TBL] [Abstract][Full Text] [Related]
17. Radioactivity levels in the mouse organs following administration of tritiated 2-methyl-piperazine dithioformate, a new radioprotector. Vertua R; Furlani A Arzneimittelforschung; 1971 Apr; 21(4):551-3. PubMed ID: 5108160 [No Abstract] [Full Text] [Related]
18. Protection of cellular and mitochondrial functions against liver ischemia by N-benzyl-N'-(2-hydroxy-3,4-dimethoxybenzyl)-piperazine (BHDP), a sigma1 ligand. Klouz A; Saïd DB; Ferchichi H; Kourda N; Ouanes L; Lakhal M; Tillement JP; Morin D Eur J Pharmacol; 2008 Jan; 578(2-3):292-9. PubMed ID: 17964567 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and initial PET imaging of new potential NK1 receptor radioligands 1-[2-(3,5-bis-trifluoromethyl-benzyloxy)-1-phenyl-ethyl]-4-[11C]methyl-piperazine and {4-[2-(3,5-bis-trifluoromethyl-benzyloxy)-1-phenyl-ethyl]-piperazine-1-yl}-acetic acid [11C]methyl ester. Gao M; Mock BH; Hutchins GD; Zheng QH Nucl Med Biol; 2005 Jul; 32(5):543-52. PubMed ID: 15982585 [TBL] [Abstract][Full Text] [Related]
20. Discovery of 1-[2-[(1S)-(3-dimethylaminopropionyl)amino-2-methylpropyl]-4-methylphenyl]-4-[(2R)-methyl-3-(4-chlorophenyl)-propionyl]piperazine as an orally active antagonist of the melanocortin-4 receptor for the potential treatment of cachexia. Chen C; Jiang W; Tucci F; Tran JA; Fleck BA; Hoare SR; Joppa M; Markison S; Wen J; Sai Y; Johns M; Madan A; Chen T; Chen CW; Marinkovic D; Arellano M; Saunders J; Foster AC J Med Chem; 2007 Nov; 50(22):5249-52. PubMed ID: 17918824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]